Janus Henderson Group Ltd.
Institutional investor · Portfolio as of Q2 2019
Top Holdings1,370 positions
Microsoft Corp. | 53M | $7.1B | 3.8% | — | — | — | First report 0 |
MasterCard Incorporated | 14.6M | $3.9B | 2.1% | — | — | — | First report 0 |
Amazon.com, Inc. | 1.8M | $3.4B | 1.9% | — | — | — | First report 0 |
Alphabet Inc. | 2.9M | $3.1B | 1.7% | — | — | — | First report 0 |
Apple Inc. | 15M | $3B | 1.6% | — | — | — | First report 0 |
Adobe Inc | 8M | $2.4B | 1.3% | — | — | — | First report 0 |
Merck & Co., Inc | 24.8M | $2.1B | 1.1% | — | — | — | First report 0 |
BOEING CO | 5.6M | $2B | 1.1% | — | — | — | First report 0 |
SALESFORCE COM INC | 13.2M | $2B | 1.1% | — | — | — | First report 0 |
Texas Instruments Inc. | 15.9M | $1.8B | 1.0% | — | — | — | First report 0 |
DISNEY WALT CO | 12.2M | $1.7B | 0.9% | — | — | — | First report 0 |
Boston Scientific Corporation | 39.3M | $1.7B | 0.9% | — | — | — | First report 0 |
Meta Platforms Inc | 8.3M | $1.6B | 0.9% | — | — | — | First report 0 |
UnitedHealth Group Inc. | 6.4M | $1.6B | 0.9% | — | — | — | First report 0 |
Visa Inc | 8.9M | $1.5B | 0.8% | — | — | — | First report 0 |
Abbott Laboratories | 17M | $1.4B | 0.8% | — | — | — | First report 0 |
Netflix, Inc. | 3.5M | $1.3B | 0.7% | — | — | — | First report 0 |
INTUIT | 4.8M | $1.2B | 0.7% | — | — | — | First report 0 |
McDonald's Corp. | 5.5M | $1.2B | 0.6% | — | — | — | First report 0 |
Home Depot Inc. | 5.5M | $1.2B | 0.6% | — | — | — | First report 0 |
Janus Henderson Group Ltd. manages $184.4B across 1370 positions as of Q2 2019. Top holdings: MSFT (3.8%), MA (2.1%), AMZN (1.9%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1.5/5.0.
First quarter we have for this fund: 1370 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $184.4B across 1370 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR